Company profile
Hangzhou Weben Pharma Co., Ltd
Privately held: no public share price (Likely an alternate transliteration of Hangzhou Weiben Pharmaceutical (the transliteration itself is unverified on a primary source); no public listing found under either spelling. [resolved 2026-08-05 by resolve-null-is-public; source: https://synapse.patsnap.com/organization/57185949420cfe876d0ceb56c3a334dd]) · China
Assets
(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Phase 1 | c-Myc | Acute Myeloid Leukemia |
Upcoming events
Research
Sign in to access ResearchUnlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Sign in to access ResearchUnlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.